Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; WillingMed Technology (Beijing) Co., Ltd, Beijing 100176, China; Beijing ChosenMed Clinical Laboratory Co., Ltd., Beijing 100176, China.
Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
J Hazard Mater. 2024 Jan 5;461:132590. doi: 10.1016/j.jhazmat.2023.132590. Epub 2023 Sep 22.
Mutations that activate oncogenes and deactivate tumor suppressor genes are widely recognized as significant contributors to cancer development. We investigated relationships between heavy metal exposure and the frequencies and types of gene mutations in patients with lung adenocarcinoma (LUAD) and colorectal cancer (CRC). Plasma concentrations of arsenic (As), cadmium (Cd), chromium (Cr), mercury (Hg), and lead (Pb) were measured using inductively coupled plasma mass spectrometry (ICPMS), and next-generation sequencing (NGS) of 1123 cancer-related genes was performed using the tumor tissues. Through Bayesian kernel machine regression (BKMR) analysis, we found associations between the integrated concentrations of the heavy metals and the number of gene mutations, especially insertions/deletions (indels), and Pb, As, and Cd were found to be the most significant contributors to the increased mutation rates. We extracted previously established mutational signatures and observed that they exhibit significant correlations with metal exposure. Moreover, we detected substantial shifts in the mutational landscape when comparing groups with high and low metal exposures. Several frequently mutated genes displayed positive correlations with metal exposure, whereas EGFR indels showed a negative association with Cd exposure. These findings suggest that heavy metal exposure can impact genomic stability in cancer-related genes, underscoring the importance of heavy metal exposure in cancer development.
突变激活癌基因和失活肿瘤抑制基因被广泛认为是癌症发展的重要因素。我们研究了重金属暴露与肺腺癌(LUAD)和结直肠癌(CRC)患者基因突变的频率和类型之间的关系。使用电感耦合等离子体质谱法(ICPMS)测量血浆中砷(As)、镉(Cd)、铬(Cr)、汞(Hg)和铅(Pb)的浓度,并使用肿瘤组织进行 1123 个癌症相关基因的下一代测序(NGS)。通过贝叶斯核机器回归(BKMR)分析,我们发现重金属综合浓度与基因突变数量之间存在关联,尤其是插入/缺失(indels),并且发现 Pb、As 和 Cd 是导致突变率增加的最主要因素。我们提取了先前建立的突变特征,并观察到它们与金属暴露显著相关。此外,当比较高暴露和低暴露组时,我们检测到突变景观发生了显著变化。一些经常发生突变的基因与金属暴露呈正相关,而 EGFR indels 与 Cd 暴露呈负相关。这些发现表明,重金属暴露会影响癌症相关基因的基因组稳定性,凸显了重金属暴露在癌症发展中的重要性。